Phase 1 Study of ARQ 761, a Β-Lapachone Analogue That Promotes NQO1-mediated Programmed Cancer Cell Necrosis
British Journal of Cancer- United Kingdom
doi 10.1038/s41416-018-0278-4
Full Text
Abstract
Available in
Date
October 1, 2018
Authors
Publisher
Springer Science and Business Media LLC